Key Financial Data Of Group

Mochida Pharmaceutical Co.,Ltd. - Filing #7323284

Concept As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
Key financial data of group
Business results of group
Net sales
94,243,000,000 JPY
102,885,000,000 JPY
95,486,000,000 JPY
103,261,000,000 JPY
102,439,000,000 JPY
110,179,000,000 JPY
95,334,000,000 JPY
102,995,000,000 JPY
94,837,000,000 JPY
101,799,000,000 JPY
Ordinary profit (loss)
5,355,000,000 JPY
6,037,000,000 JPY
8,971,000,000 JPY
9,085,000,000 JPY
13,539,000,000 JPY
14,799,000,000 JPY
11,626,000,000 JPY
12,260,000,000 JPY
7,984,000,000 JPY
9,154,000,000 JPY
Profit (loss) attributable to owners of parent
4,547,000,000 JPY
6,649,000,000 JPY
10,569,000,000 JPY
8,587,000,000 JPY
4,598,000,000 JPY
Comprehensive income
7,567,000,000 JPY
5,001,000,000 JPY
7,619,000,000 JPY
11,412,000,000 JPY
873,000,000 JPY
Net assets
127,967,000,000 JPY
126,336,000,000 JPY
125,109,000,000 JPY
126,775,000,000 JPY
128,646,000,000 JPY
126,385,000,000 JPY
126,974,000,000 JPY
124,894,000,000 JPY
120,665,000,000 JPY
118,226,000,000 JPY
Total assets
158,800,000,000 JPY
152,166,000,000 JPY
152,386,000,000 JPY
158,831,000,000 JPY
163,139,000,000 JPY
156,837,000,000 JPY
161,791,000,000 JPY
155,605,000,000 JPY
157,488,000,000 JPY
147,964,000,000 JPY
Net assets per share
3,609.64
3,563.63
3,424.59
3,470.18
3,424.21
3,364.03
3,317.92
3,263.57
3,113.69
3,050.75
Basic earnings (loss) per share
130.27
126.80
195.10
178.93
274.03
277.39
232.56
222.29
114.13
117.56
Diluted earnings per share
Equity-to-asset ratio
0.806 xbrli:pure
0.830 xbrli:pure
0.821 xbrli:pure
0.798 xbrli:pure
0.789 xbrli:pure
0.806 xbrli:pure
0.785 xbrli:pure
0.803 xbrli:pure
0.766 xbrli:pure
0.799 xbrli:pure
Rate of return on equity
0.037 xbrli:pure
0.036 xbrli:pure
0.058 xbrli:pure
0.052 xbrli:pure
0.083 xbrli:pure
0.083 xbrli:pure
0.074 xbrli:pure
0.069 xbrli:pure
0.037 xbrli:pure
0.037 xbrli:pure
Price-earnings ratio
24.7 xbrli:pure
25.4 xbrli:pure
17.1 xbrli:pure
18.7 xbrli:pure
13.6 xbrli:pure
13.5 xbrli:pure
18.4 xbrli:pure
19.3 xbrli:pure
36.5 xbrli:pure
35.5 xbrli:pure
Net cash provided by (used in) operating activities
-7,480,000,000 JPY
7,297,000,000 JPY
7,459,000,000 JPY
9,198,000,000 JPY
9,347,000,000 JPY
Net cash provided by (used in) investing activities
74,000,000 JPY
-2,949,000,000 JPY
-2,007,000,000 JPY
-880,000,000 JPY
-1,760,000,000 JPY
Net cash provided by (used in) financing activities
-6,393,000,000 JPY
-6,884,000,000 JPY
-5,956,000,000 JPY
-5,112,000,000 JPY
-5,328,000,000 JPY
Cash and cash equivalents
24,290,000,000 JPY
38,010,000,000 JPY
40,515,000,000 JPY
40,987,000,000 JPY
37,791,000,000 JPY
Number of employees
128 xbrli:pure
117 xbrli:pure
1,522 xbrli:pure
1,247 xbrli:pure
1,252 xbrli:pure
1,529 xbrli:pure
1,544 xbrli:pure
1,280 xbrli:pure
1,558 xbrli:pure
1,298 xbrli:pure
1,581 xbrli:pure
1,298 xbrli:pure
Average number of temporary employees
21 xbrli:pure
11 xbrli:pure
495 xbrli:pure
194 xbrli:pure
202 xbrli:pure
515 xbrli:pure
503 xbrli:pure
195 xbrli:pure
504 xbrli:pure
189 xbrli:pure
482 xbrli:pure
180 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.